Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Jade Biosciences, Inc. | 0 | 1,525,820 | +1,525,820 | 0 | 15,243 | 18.56% | +15,243 |
| CRISPR Therapeutics AG(CRSP) | 498,558 | 498,558 | 0 | 16,966 | 24,250 | 29.52% | +7,284 |
| Skye Bioscience, Inc.(SKYE) | 2,007,704 | 2,007,704 | 0 | 3,192 | 8,392 | 10.22% | +5,200 |
| Tempest Therapeutics, Inc.(TPST) | 0 | 269,772 | +269,772 | 0 | 1,834 | 2.23% | +1,834 |
| Repare Therapeutics, Inc. | 2,646,657 | 2,646,657 | 0 | 2,609 | 3,679 | 4.48% | +1,070 |
| Monte Rosa Therapeutics, Inc.(GLUE) | 5,652,922 | 5,652,922 | 0 | 26,230 | 25,495 | 31.04% | -735 |
| Adverum Biotechnologies, Inc. | 506,821 | 506,821 | 0 | 2,215 | 1,090 | 1.33% | -1,125 |
| Tempest Therapeutics, Inc.(TPST) | 3,507,055 | 0 | -3,507,055 | 2,588 | 0 | — | -2,588 |
| Contineum Therapeutics, Inc.(CTNM) | 918,163 | 542,628 | -375,535 | 6,409 | 2,154 | 2.62% | -4,255 |